medigraphic.com

2019, Number 1

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2019; 20 (1)

Effectiveness of arterial surgery in diabetic patients over a period of five years

Bravo YCV, Savigne GWO, Aldama FA

Language: Spanish
References: 50
Page: 1-19
PDF size: 217.29 Kb.


ABSTRACT

Introduction: Diabetic macroangiopathy is a serious problem for patients who suffer it; and revascularization surgery is an alternative to its treatment.
Objective: To show the effectiveness of arterial surgeries performed in diabetic patients over a period of five years.
Methods: Descriptive, retrospective study in 71 clinical records of patients with diabetic macroangiopathy who received arterial surgery at the National Institute of Angiology and Vascular Surgery (January / 2011- December / 2015). The variables analyzed were: age, gender, skin color, survival of the limb, state of permeability of the grafts and frequency of deaths, which as a whole will measure the effectiveness of the surgery.
Results: There was a linear increase in revascularization surgeries. The mean age was 64.5 ± 9.7 years, with 67. 6% of people over 60 years old, and more than 60 % were men. 52.9 % had white skin, 80.3 % had grade 4 according to Fontaine and 66.2 % had severe arterial occlusion. In more than 90 %, derivative surgery or endarterectomy was performed; 87.3 % had affectations in the infrainguinal sector and in 64.8 % the limb survived. There were no perioperative deaths or deaths at six months. 63 % of the surgeries were permeable at six months.
Conclusions: Arterial surgeries were effective because the majority of patients maintained the affected limb and there were no perioperative deaths neither at the six months evaluation; in addition, most of the grafts were permeable in that time.


REFERENCES

  1. Hinchliffe R, Brownrigg J, Andros G, Apelqvist J, Boyko E, Fitridge R, et al. Effectiveness of revascularization of the ulce-rated foot in patients with diabetes and peripheral artery disease: A systematic review. Diab Metab Res Rev. 2016; 32:136-44.

  2. Armstrong DG, Mills JL. Toward a change in syntax in diabetic foot care: prevention equals remission. J Am Podiatr Med Assoc. 2013;103:161-2.

  3. krepnek GH, Mills J, Armstrong DG. The inpatient burden of diabetic foot disease. Chicago, IL: American Diabetes Association; 2013.

  4. Goodney PP, Holman K, Henke PK, Travis LL, Dimick JB, Stukel TA, et al. Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg. 2013;57:1471- 80.

  5. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. New Eng J Med. 2017;376:2367-75.

  6. Jones DW, Schanzer A, Zhao Y, MacKenzie TA, Nolan BW, Conte MS, et al. Growing impact of restenosis on the surgical treatment of peripheral arterial disease. J Am Heart Assoc. 2013;2:e000345.

  7. Schaper NC, Andros G, Apelqvist J, Bakker K, Lammer J, Lepantalo M, et al. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot. Diab Metab Res Rev. 2012;28:236-7.

  8. Goodney PP, Tarulli M, Faerber AE, Schanzer A, Zwolak RM. Fifteen-year trends in lower limb amputation, revascularization, and preventive measures among medicare patients. JAMA surgery. 2015;150:84-6.

  9. Masaki H, Tabuchi A, Yunoki Y, Kubo H, Nishikawa K, Yakiuchi H, et al. Collective Therapy and therapeutic strategy for critical limb ischemia. Ann Vasc Dis. 2013;6(1):27–32.

  10. Pomposelli F. Arterial imaging in patients with lower extremity ischemia and diabetes mellitus. J Vasc Surg. 2010;52:815-915.

  11. Meyer A, Goller K, Horch RE, Beier JP, Taeger CD, Arkudas A, et al. Results of combined vascular reconstruction and free flap transfer for limb salvage in patients with critical limb ischemia. J Vasc Surg. 2015;61:1239-48.

  12. Todd KE, Ahanchi SS, Maurer CA, Kim JH, Chipman CR, Panneton JM. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. J Vasc Surg. 2013;58:941-8.

  13. Fontaine R, Kieny R, Gangloff JM, Cuny A, Suhler A, Gonzales I, et al. Long-term results of restorative arterial surgery in obstructive diseases of the arteries. J Cardiovasc Surg. 1964;5:463-4

  14. Hinchliffe RJ, Brownrigg JRW, Apelqvist J, Boyko EJ, Fitridge R, Mills JL, Reekers; . International Working Group on the Diabetic Foot. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diab Met Rev Res. 2016. 32: 37-44.

  15. World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. 64th WMA General Assembly. Fortaleza, Brazil: WMA; 2013. Acceso: 28/10/2018. Available at: https://www.wma.net/wpcontent/ uploads/2016/11/DoH-Oct2013-JAMA.pdf

  16. Mustapha JA, Finton SM, Diaz-Sandoval LJ, Saab FA, Miller LE Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease. Circulation Cardiovasc Interv. 2016;9:e003468.

  17. Parvataneni KC, Piyaskulkaew C, Szpunar S, Sharma T, Patel V, Patel S, et al. Relation of baseline renal dysfunction with outcomes in patients undergoing popliteal and infrapopliteal percutaneous peripheral arterial interventions. Am J Cardiol. 2016;118:298- 302.

  18. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): the TASC Steering Comittee. Ann Vasc Dis. 2015;8:343-57.

  19. Forsythe RO, Brownrigg J, Hinchliffe RJ. Peripheral arterial disease and revascularization of the diabetic foot. Diab Obes Metabol. 2015;17: 435-44.

  20. Skrepnek GH, Armstrong DG, Mills JL. Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010. J Vasc Surg. 2014;60:1255-65.

  21. Darling JD, McCallum JC, Soden PA, Korepta L, Guzman RJ, Wyers MC, et al. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limbthreatening ischemia. J Vasc Surg. 2017;66:466-75

  22. Darling JD, Bodewes TCF, Deery SE, Guzman RJ, Wyers M, Hamdan AD, et al. Outcomes of lower extremity revascularization between patients with and without diabetes. 2017. Access: 2017/09/17. Available at: en:https://dspace.library.uu.nl/bitstream/handle/1874/351285/Bodewes.pdf?sequence=1#pag e=43

  23. Mills JL. Lower limb ischaemia in patients with diabetic foot ulcers and gangrene: recognition, anatomic patterns and revascularization strategies. Diabet Metab Res Rev. 2016;32:239-45

  24. Medhekar AN, Mix DS, Aquina CT, Trakimas LE, Noyes K, Fleming FJ, et al. Outcomes for critical limb ischemia are driven by lower extremity revascularization volume, not distance to hospital. J Vasc Surg. 2017;66:476-87.

  25. Althouse AD, Abbott JD, Forker AD, Bertolet M, Barinas-Mitchell E, Thurston RC, et al. Risk Factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) trial. Diabet Care. 2014;37:1346-52.

  26. Ballotta E, Toniato A, Piatto G, Mazzalai F, Da Giau G. Lower extremity arterial reconstruction for critical limb ischemia in diabetes. J Vasc Surg. 2014;59:708-19.

  27. Hahn HM, Jeong YS, Hong YS, Won JH, Lim SH, Kim J, et al. Use of revascularized artery as a recipient in microvascular reconstruction of the lower leg: An analysis of 62 consecutive free flap transfers. J Plast Reconst Aesth Surg. 2017;70:606-17.

  28. Engelhardt M, Boos J, Bruijnen H, Wohlgemuth W, Willy C, Tannheimer M, et al. Critical limb ischaemia: initial treatment and predictors of amputation-free survival. Eur J Vasc Endovasc Surg. 2012;43:55-61.

  29. Lejay A, Georg Y, Tartaglia E, Gaertner S, Geny B, Thaveau F, et al. Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann Vasc Surg. 2014;28:983-9.

  30. Palena LM, Diaz-Sandoval LJ, Jabalera EG, Perez OP, Sultato E, Brigato C, et al. Drugcoated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia. Cardiovas Revasc Med. 2018;19(1Pt B):83-87. Epub 2017 Jun 20. Acceso: 10/10/2018. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28648324doi: 10.1016/j.carrev.2017.06.006

  31. Barshes NR, Bechara CF, Pisimisis G, Kougias P. Preliminary experiences with early primary closure of foot wounds after lower extremity revascularization. Ann Vasc´Surg. 2014;28:48–52.

  32. Pavé M, Benadiba L, Berger L, Gouicem D, Hendricks M, Plissonnier D. Below-the- Knee Angioplasty for Critical Limb Ischemia: Results of a series of 157 procedures and impact of the Angiosome Concept. Ann Vasc Surg. 2016;39:199-207.

  33. Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first choice revascularisation procedure in diabetic patients with critical limb ischaemia: prospective study of 993 consecutive patients hospitalised and followed between1999-2003. Eur J Vasc Endovasc Surg. 2005;29:620–7.

  34. Antoniou GA, Chalmers N, Georgiadis GS, Lazarides MK, Antoniou SA, SerracinoInglott F, et al. A meta-analysis of endovascular vs. surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg. 2013;57:242-53

  35. Bae JI, Won JH, Han SH, Lim SH, Hong YS, Kim JY, et al. Endovascular revascularization for patients with critical limb ischemia: impact on wound healing and long term clinical results in 189 limbs. Korean J Radiol. 2013;14:430-8.

  36. Elgzyri T, Larsson J, Nyberg P, Thörne J, Eriksson KF, Apelqvist J. Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg. 2014;48:440-6

  37. Fu X, Zhang Z, Liang K, Shi S, Wang G, Zhang K, et al. Angioplasty versus bypass surgery in patients with critical limb ischemia-a meta-analysis. Int J Clin ExpMed. 2015;8:10595-602

  38. Peña-Cortés R, Sanz-Pastor N, Fernández-Samos R, Alonso-Argüeso G, Ortega-Martín JM, Vaquero-Morillo F. Tratamiento de la isquemia crítica de las extremidades inferiores. Cirugía distal y endovascular. Angiología. 2012;64: 232-8.

  39. Morris-Stiff G, Moawad M, Appleton N, Davies G, Hicks E, Davies C, et al. Long-term clinical outcome following lower limb arterial angioplasty. Ann R Coll Surg Engl. 2011;93:250-4.

  40. Darling JD, Soden PA, Zettervall SL, Guzman RJ, Wyers MC, Hamdan AD, et al. Lower extremity revascularization in diabetic and nondiabetic patients. J Vasc Surg. 2016;63:114-5

  41. Pennywell DJ, Tan TW, hang WW. Optimal management of infrainguinal arterial occlusive disease. Vasc Health Risk Manag. 2014;0:599-608.

  42. Klein AJ, Pinto DS, Gray BH, Jaff MR, White CJ, Drachman DE, SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use. Catheter Cardiovasc Interv. 2014 84: 529-38.

  43. Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg. 2007;46:1180-90.

  44. Mills JL, Fujitani RM, Taylor SM. Contribution of routine intraoperative completion arteriography to early infrainguinal bypass patency. Am J Surg. 1992;164:506-11.

  45. Setacci C, Sirignano P, Mazzitelli G, Setacci F, Messina G, Glazerano G, et al. Diabetic foot: surgical approach in emergency. Int J Vasc Med. EL Cairo: Hindawi; 2013. Acceso: 25/19/2018. Disponible en. https://www.hindawi.com/journals/ijvm/2013/296169/

  46. Dohmen A, Eder S, Euringer W, Zeller T, Beyersdorf F. Chronic critical limb ischemia- Dtsch Arztebl Int. 2012;109:95-101.

  47. Shammas An, Jeon-Slaughter H, Tsai S, Khalili H, Ali M, Xu H el al. Major limb outcomes following lower extremity endovascular revascularization in patients with and without diabetes. J Endovasc Ther. 2017;24:376-82.

  48. An JH, Jang YM, Song KH, Kim SK, Park SW, Jung HG, et al. Outcome of percutaneous transluminal angioplasty in diabetic patients with critical limb ischaemia. Exp Clin Endocrinol Diab. 2014;122:50-4.

  49. Zhan LX, Bharara M, White M, Bhatnagar S, Lepow B, Armstrong DG, et al. Comparison of initial hemodynamic response after endovascular therapy and open surgical bypass in patients with diabetes mellitus and critical limb ischemia. J Vasc Surg. 2012; 56:380-6.

  50. Brooke BS, Kraiss LW, Stone DH, Nolan B, De Martino RR, Reiber GE, et al. Improving outcomes for diabetic patients undergoing revascularization for critical limb ischemia: Does the quality of outpatient diabetic care matter? Ann Vasc Surg. 2014; 28:179- 1728.




2020     |     www.medigraphic.com